Anti-Tumor Efficacy and Biomarker Evaluation of Agonistic Anti-Ox40 Antibodies in Preclinical Models
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p253
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2014
Authors
Publisher
BMJ